1. Home
  2. PRTC vs TMCI Comparison

PRTC vs TMCI Comparison

Compare PRTC & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • TMCI
  • Stock Information
  • Founded
  • PRTC 2015
  • TMCI 2014
  • Country
  • PRTC United States
  • TMCI United States
  • Employees
  • PRTC N/A
  • TMCI N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PRTC Health Care
  • TMCI Health Care
  • Exchange
  • PRTC Nasdaq
  • TMCI Nasdaq
  • Market Cap
  • PRTC 431.1M
  • TMCI 516.6M
  • IPO Year
  • PRTC N/A
  • TMCI 2021
  • Fundamental
  • Price
  • PRTC $19.78
  • TMCI $8.32
  • Analyst Decision
  • PRTC Buy
  • TMCI Hold
  • Analyst Count
  • PRTC 1
  • TMCI 8
  • Target Price
  • PRTC $45.00
  • TMCI $9.00
  • AVG Volume (30 Days)
  • PRTC 2.1K
  • TMCI 389.9K
  • Earning Date
  • PRTC 04-24-2025
  • TMCI 05-06-2025
  • Dividend Yield
  • PRTC N/A
  • TMCI N/A
  • EPS Growth
  • PRTC N/A
  • TMCI N/A
  • EPS
  • PRTC N/A
  • TMCI N/A
  • Revenue
  • PRTC $468,000.00
  • TMCI $209,357,000.00
  • Revenue This Year
  • PRTC N/A
  • TMCI $10.86
  • Revenue Next Year
  • PRTC $160.00
  • TMCI $10.06
  • P/E Ratio
  • PRTC N/A
  • TMCI N/A
  • Revenue Growth
  • PRTC N/A
  • TMCI 11.88
  • 52 Week Low
  • PRTC $16.30
  • TMCI $3.92
  • 52 Week High
  • PRTC $34.00
  • TMCI $13.24
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 65.61
  • TMCI 44.87
  • Support Level
  • PRTC $16.30
  • TMCI $8.34
  • Resistance Level
  • PRTC $18.34
  • TMCI $8.87
  • Average True Range (ATR)
  • PRTC 0.43
  • TMCI 0.42
  • MACD
  • PRTC 0.28
  • TMCI 0.05
  • Stochastic Oscillator
  • PRTC 100.00
  • TMCI 56.25

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

Share on Social Networks: